The Pharma Letter
Gilead aims to license hepatitis C drug to 3-4 Indian firms
We're nailing down the geographical scope, and we should have these licences in place and ready to go in short order," Samuel said on a visit to London for an international liver conference. He said Gilead was looking to strike deals with firms that ...
WHO Calls For 'Concerted Effort' To Bring Down Hepatitis C Drug Costs
WHO joins clamor to make new Hepatitis C pills affordable